Human Reproduction, Vol. 15, No. 2, 469-473,
February 2000
© 2000 European Society of Human Reproduction and Embryology
Predictive value of plasma human chorionic gonadotrophin following assisted conception treatment
Sheffield Fertility Centre, 2426 Glen Road, Sheffield S7 1RA, UK
A total of 429 pregnancies after assisted conception treatment was analysed, using receiver operator characteristic curves. The best balance between sensitivity and specificity for predicting viable (single and multiple births) and non-viable (fetal heart positive abortions, ectopic and biochemical pregnancies) outcomes was human chorionic gonadotrophin (HCG) 50 IU/l on day 14 and 200 IU/l on day 21 after treatment. Utilizing these indices all pregnancies could be classified into one of four groups. In group A (day 14 HCG <50 IU/l and day 21 <200 IU/l), the probability of a birth was 0%, pregnancy loss 72% and ectopic pregnancy 28%. Conversely for group D (day 14 HCG >50 IU/l and day 21 >1000 IU/l), the likelihood of a birth was 90%, pregnancy loss 8% and ectopic pregnancy only 1%. Between groups A and D there was, as expected, a gradually shifting balance in favour of a reduction in ectopic (28, 13, 3, 1%) and biochemical pregnancies (70, 36, 33, 2%) and an increase in fetal heart positive pregnancy losses (2, 6, 13, 7%) and births (0, 44, 50, 90%). The majority of multiple pregnancies (98%) occurred in group D. Two accurately linked HCG measurements allowed a greater predictive accuracy of pregnancy outcome than could be obtained using either alone.
Key words: assisted conception/chorionic gonadotrophin/in-vitro fertilization/outcome/predictive value
1 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Kane, R. Kelly, P. T. K. Saunders, and H. O. D. Critchley Proliferation of Uterine Natural Killer Cells Is Induced by Human Chorionic Gonadotropin and Mediated via the Mannose Receptor Endocrinology, June 1, 2009; 150(6): 2882 - 2888. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tong, L. Rombauts, J. Onwude, B. Marjono, and E.M. Wallace Highly specific and sensitive rise in Days 14 17 pro-{alpha}C inhibin with clinical pregnancy after frozen embryo transfer with ovulatory cycles Hum. Reprod., August 1, 2007; 22(8): 2249 - 2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fernandez and A. Gervaise Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy Hum. Reprod. Update, November 1, 2004; 10(6): 503 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tong, L. Rombauts, A. Mulder, B. Marjono, J. L. Onwude, and E. M. Wallace Increased Day 15-17 Serum Pro-{alpha}C Inhibin Levels Specific to Successful Pregnancy J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4464 - 4468. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Winter, J. Wang, M. J. Davies, and R. Norman Early pregnancy loss following assisted reproductive technology treatment Hum. Reprod., December 1, 2002; 17(12): 3220 - 3223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Poikkeus, V. Hiilesmaa, and A. Tiitinen Serum HCG 12 days after embryo transfer in predicting pregnancy outcome Hum. Reprod., July 1, 2002; 17(7): 1901 - 1905. [Abstract] [Full Text] [PDF] |
||||



